IGF1 and skin cancer: Elevated PI3K/AKT activity and subsequent activation of one or more downstream effector pathways contributed significantly to the tumor-promoting action of IGF-1 in the epidermis of BK5 (Keratin 5, derived from epithelial cells), a skin cancer model.